Cargando…
Resolution of COVID-19 induced anosmia following treatment with ST266
BACKGROUND: Persistent anosmia following COVID-19 disease affects a significant subset of patients. Symptoms of this olfactory dysfunction negatively impact patient quality of life, and effective treatments are lacking; therefore, novel therapies that restore the ability to smell have tremendous cli...
Autores principales: | Bhutani, Devica L., Ross, Ahmara G., Lehman, Amanda Y., Shindler, Kenneth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444303/ https://www.ncbi.nlm.nih.gov/pubmed/36090590 http://dx.doi.org/10.1016/j.xocr.2022.100475 |
Ejemplares similares
-
Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells
por: Willett, Keirnan, et al.
Publicado: (2021) -
Topical application of ST266 reduces UV-induced skin damage
por: Guan, Linna, et al.
Publicado: (2017) -
RGC and Vision Loss From Traumatic Optic Neuropathy Induced by Repetitive Closed Head Trauma Is Dependent on Timing and Force of Impact
por: Khan, Reas S., et al.
Publicado: (2021) -
Features of anosmia in COVID-19
por: Klopfenstein, T., et al.
Publicado: (2020) -
Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis
por: Ross, Ahmara G., et al.
Publicado: (2022)